Dudediligence.

iSpecimen Inc

ISPCNASDAQ · Services-Commercial Physical & Biological Research
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

1.52M

on 2026-06-30, from 12K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-20 and 1-for-40 reverse splits; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$100.0M

S-3 of 2025-10-23. None sold under it to 2026-10-05. S-3 ↗

1 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-14 is not read yet.

Cash

2.5 quarters

$4.4M on 2026-06-30 ÷ $1.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-08-05Public offering incl. 2.85M pre-funded3,846,153$1.30$5.0M424B4 ↗
2026-08-05Private placement incl. 2.85M pre-funded5,699,846not read$5.0M8-K ↗
2026-05-08Private placement488,281$5.12$2.5M8-K ↗
2025-12-30Private placement6,875$800.00$5.5M8-K ↗
2025-07-31Private placement1,559,828$1.122$1.8M8-K ↗
2025-07-23Public offering incl. 4.23M pre-funded5,714,283$0.70$4.0M424B4 ↗
2024-10-29Public offering incl. 1.53M pre-funded1,666,666$3.00$5.0M424B4 ↗

Also on file: a 1-for-20 reverse split, 2024-09-11 8-K ↗ · a 1-for-40 reverse split, 2026-04-29 8-K ↗